2,591 Hits in 7.8 sec

Marketing Analysis of the Pharmaceutical Industry

Peter Enos
Many major pharmaceutical companies operate globally but are heavily regulated due to the restriction of direct-to-consumer-advertising in all countries except the United States and New Zealand (Ham, 2008  ...  Lastly, the paper will provide an overview of the market segments and target markets for the pharmaceutical industry.  ...  Traditional advertising through the use of direct-to-consumer advertising (DTCA), although limited to only the US and New Zealand, also play a major role in marketing drugs to consumers (Oliver, 2017)  ... 
doi:10.6084/m9.figshare.16640323.v1 fatcat:ybqhphu3y5e65ndrmsw23rgwsa

Financial Aspects and the Future of the Pharmaceutical Industry in the United States of America

Jasenko Karamehic, Ognjen Ridic, Goran Ridic, Tomislav Jukic, Jozo Coric, Djemo Subasic, Mirsad Panjeta, Lejla Zunic, Izet Masic
2013 Materia socio-medica  
The goal of this review paper is to show the present conditions and future trends of the pharmaceutical industry in the U.S.  ...  The U.S. pharmaceutical industry is defined by the U.S.  ...  The healthcare reform law (PPACA) is expected to have a significant impact on the pharmaceutical industry by both expanding the pool of insured potential consumers by 32 million people over the next decade  ... 
doi:10.5455/msm.2013.25.286-290 pmid:24511277 pmcid:PMC3914743 fatcat:dqw2ktonwvdqdgtn5qe7vkq4ou

Market Structure, R&D and Advertising in the Pharmaceutical Industry

Catherine Matraves
2003 Journal of Industrial Economics  
ABSTRACT Market Structure, R&D and Advertising in the Pharmaceutical Industry by Catherine Matraves * Recent developments in the literature on market structure have allowed the generation of a few key  ...  testable predictions from the theory of strategic behaviour.  ...  Additionally, substantial increases in advertising expenditure have been within direct-to-consumer advertising (Pharmaceutical Online), implying that the effectiveness of advertising has indeed increased  ... 
doi:10.1111/1467-6451.00096 fatcat:rzz2jaaaara6fiwv7cchy5f2je

Toward Allocative Efficiency in the Prescription Drug Industry

Robert C. Guell, Marvin Fischbaum
1995 Milbank Quarterly  
The use of the concept of consumers' surplus to measure changes in material well-being is somewhat controversial among economists.  ...  We will attempt to bypass this problem by investigating whether global economic efficiency could be improved by changing the rules of the game under which the pharmaceutical industry operates.  ... 
doi:10.2307/3350257 pmid:7776946 fatcat:ajpdbgh5bze77edpoid6azpuai

Detailing vs. Direct-to-Consumer Advertising in the Prescription Pharmaceutical Industry

Ram Bala, Pradeep Bhardwaj
2010 Management science  
They also thank Manoj Payardha and Ajay Abraham for their help with certain numerical aspects of this paper.  ...  Texas at Dallas, and University of California, San Diego, whose comments helped to improve this paper substantially.  ...  to a major shift in this direct-to-consumer advertising (DTCA) of prescription drugs.  ... 
doi:10.1287/mnsc.1090.1074 fatcat:oznddsd7v5h4rkqo6uzr3xhz2q

Strategies for internationalisation of SMEs – based on the example of the company operating in the creative industries sector

Monika Fabińska, Department of Entrepreneurship and Industrial Policy, Faculty of Management, University of Lodz
2018 Studia i Materiały Wydziału Zarządzania UW  
The aim of the paper is (i) to conduct an analysis of the target markets (FMCG, pharmaceuticals, and advertising services) in selected Scandinavian countries and (ii) to develop recommendations for optimum  ...  -these are only few features of the global market.  ...  In 2011, the first Internet pharmacy was set up (Wai, Noichangkid, 2012) . 99% of the pharmaceutical industry in Sweden consists of pharmacies where prescription drugs and over the counter ones can be  ... 
doi:10.7172/1733-9758.2018.26.8 fatcat:ssmcsnc47zge3gvnbqasykx3ai

The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy

D. G. Arnold, J. L. Oakley
2013 Journal of Health Politics Policy and Law  
Prescription Drugs and Administrative Costs The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry’s Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking  ...  Oakley Montana State University Abstract As the pharmaceutical industry lobbies European regulators to permit direct-to-consumer advertising (DTCA) of prescription drugs in the European Union, we found  ... 
doi:10.1215/03616878-2079496 pmid:23418365 fatcat:2pi2jogkfzalzotnlx3txgzceu

Undue influences on drugs and device industries distort healthcare research, and practice

Mohammad Arifur Rahman, Laila Farzana
2015 Bangladesh Journal of Bioethics  
There is an urgent need for regulation and other action towards redefining the mission of medicine towards a more objective and patient-, population- and society-benefit direction that is free from conflict  ...  The enormous financial interests involved in the development and marketing of drugs and devices may have given excessive power to these industries to influence medical research, policy, and practice.  ...  Direct-to-consumer advertising: In the United States, where such marketing practices are permitted by law, directto-consumer advertising (DTCA) is a major force of rising pharmaceutical costs 58 .  ... 
doi:10.3329/bioethics.v6i2.25741 fatcat:inedjknjovar5bqpvnq7uidnqy

Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?

Maria-Angeles de Frutos, Carmine Ornaghi, Georges Siotis
2013 Journal of Health Economics  
We show that advertising intensities are strategic substitutes, with the better quality drugs being the ones that are most advertised.  ...  The model's main results on advertising and pricing strategies are taken to the data.  ...  pharmaceutical industry available from the US Bureau of Labour Table 2 The impact of changes in t when ˇ = 1.0952, u = 4, c = 0 and k = 0.65.  ... 
doi:10.1016/j.jhealeco.2012.07.006 pmid:23237791 fatcat:g2tgahrb55hj7eonscosylujea

Four scenarios for the future of the pharmaceutical industry

Ron Bradfield, Hany El-Sayed
2009 Technology Analysis & Strategic Management  
While biotechnology promises to reshape the pharmaceutical industry, it too faces challenges: the industry as a whole is unprofitable and there is uncertainty regarding market acceptance of its products  ...  Pharmaceutical companies are facing several major interrelated challenges, the most strategic being the decline in R&D productivity resulting in empty product pipelines to replace products nearing patent  ...  Critics of the growing expenditures on direct-to-consumer advertising of drugs in the USA claim that this has not only increased the cost of drugs, it has also prompted demand for the latest drugs in favour  ... 
doi:10.1080/09537320802625280 fatcat:7ykhnmmxlnadbg4unukuro5plu

Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry

Chie Hoon Song, Jeung-Whan Han
2016 SpringerPlus  
It further discusses how the mix of competition policies and strategic instruments can be used to maintain declining revenue streams from the blockbuster business model of the pharmaceutical industry.  ...  Extending the period of the market exclusivity and responding properly to the recent agglomeration of patent expiries are pivotal to the success of pharmaceutical companies.  ...  Acknowledgements This work was supported by Medical Research Center programs to J.W.H. through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology  ... 
doi:10.1186/s40064-016-2323-1 pmid:27347468 pmcid:PMC4899342 fatcat:avudgyngenevxkedidqw6tpaja

Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review

Emmanuel Stamatakis, Richard Weiler, John P.A. Ioannidis
2013 European Journal of Clinical Investigation  
There is an urgent need for regulation and other action towards redefining the mission of medicine towards a more objective and patient-, population-and society-benefit direction that is free from conflict  ...  Expenditure on industry products (mostly drugs and devices) has spiraled over the last 15 years and accounts for substantial part of healthcare expenditure.  ...  The views expressed in this publication are those of the author(s) and not necessarily those of the NHS or the National Institute for Health Research or the Department of Health.  ... 
doi:10.1111/eci.12074 pmid:23521369 fatcat:zlq3dk6d65clfalemh7vpoyayu

Impacts of Digital Marketing on the Pharmacies Community in Saudi Arabia and Determining the Future Model of the Industry: A Cross-Sectional Questionnaire-based Study

Mansour Alyahya, Sneha Dhruvakumar, Shekar Hosahalli Siddegowda, Nagaraja Sreeharsha
2020 Indian Journal of Pharmaceutical Education and Research  
Approximately, 36 pharmacies agreed out of 51 to the fact that webinars are effective, efficient and resourceful for online engagement with all shareholders regarding the product.  ...  Pharmaceutical and telemedicine industries are now finding ways in the Kingdom of Saudi Arabia by adopting innovative and successful business models along with groundbreaking strategies using digital online  ...  audiences. 1 The factor of digitalization has also brought a new sense of competition within the pharmaceutical industry.  ... 
doi:10.5530/ijper.54.4.174 fatcat:xiow7had75b5xjr4oy27wc7idu

Brazilian Industry Policy After 1990: Focusing on the Pharmaceutical Industry

Christian Luiz Da Silva, Alexandre Oliveira
2007 Journal of Technology Management & Innovation  
Ethical products are those sold exclusively when the patient has a doctor's prescription. For that reason, laboratory advertisement is directed to doctors.  ...  X Reduction of industry idle capacity, improving the out-of consumer market population access to drugs by using public resources.  ...  X Improved agility concerning the analysis of national product requests for changing some chemical product import tariffs.  ... 
doaj:2c3160bad84845879918e6d8c24ab247 fatcat:uyireifaqffjxjeb5b36cubtsy

The Implications of WTO Accession on the Pharmaceutical Industry in China

Godfrey Yeung
2002 Journal of Contemporary China  
Given the limited capabilities on R&D and global distribution channels, and the virtual non-existence of patented drugs, the Chinese pharmaceuticals industry has little chance to enter the global market  ...  against the Chinese pharmaceuticals industry.  ...  Subsequently, drug companies spent US$1.9 billion on direct-to-consumer advertising in 1999; see Financial Times, (8 November 1999), p. 21 and (23 November 1999) 105-141.  ... 
doi:10.1080/10670560220152292 fatcat:2rkv57gu7jcyxkejwdtynpnjrm
« Previous Showing results 1 — 15 out of 2,591 results